Oncology
0 drugs are in development for Generalized Myasthenia Gravis (gMG).
- Companies
- 0
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Generalized Myasthenia Gravis (gMG) pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Generalized Myasthenia Gravis (gMG) context
Oncology·MeSH: Myasthenia Gravis (D009157)
Narrower concept of MeSH descriptor Myasthenia Gravis
Incidence
1.7 / 100K/yr